XML 38 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Correction of Immaterial Errors To Prior Period Financial Statements (Tables)
6 Months Ended
Dec. 31, 2016
Accounting Changes and Error Corrections [Abstract]  
Schedule of Correction of Immaterial Errors to Prior Period Financial Statements
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
Three Months Ended December 31, 2015
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
752,589

 
$
(9,152
)
 
$
743,437

Cost of sales
575,026

 
2,150

 
577,176

    Gross profit
177,563

 
(11,302
)
 
166,261

Selling, general and administrative expenses
82,607

 
(13,626
)
 
68,981

Amortization of acquired intangibles
4,736

 
(32
)
 
4,704

Acquisition related expenses, restructuring and integration charges
  and other
2,498

 

 
2,498

    Operating income
87,722

 
2,356

 
90,078

Interest and other financing expense, net
6,300

 

 
6,300

Other (income)/expense, net
3,065

 

 
3,065

Income before income taxes and equity in earnings of equity-
  method investees
78,357

 
2,356

 
80,713

Provision for income taxes
21,379

 
1,223

 
22,602

Equity in net loss of equity-method investees
31

 

 
31

Net income
$
56,947

 
$
1,133

 
$
58,080

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
0.55

 
$
0.01

 
$
0.56

    Diluted
$
0.55

 
$
0.01

 
$
0.56

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
103,017

 
103,017

 
103,017

    Diluted
104,161

 
104,161

 
104,161


* Net income per common share may not add in certain periods due to rounding




 
Six Months Ended December 31, 2015
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
1,439,777

 
$
(28,613
)
 
$
1,411,164

Cost of sales
1,110,167

 
(3,145
)
 
1,107,022

    Gross profit
329,610

 
(25,468
)
 
304,142

Selling, general and administrative expenses
168,861

 
(24,330
)
 
144,531

Amortization/impairment of acquired intangibles
9,408

 
(65
)
 
9,343

Acquisition related expenses, restructuring and integration charges
  and other
6,151

 
(233
)
 
5,918

    Operating income
145,190

 
(840
)
 
144,350

Interest and other financing expense, net
12,767

 

 
12,767

Other (income)/expense, net
8,466

 

 
8,466

Income before income taxes and equity in earnings of equity-
  method investees
123,957

 
(840
)
 
123,117

Provision for income taxes
35,761

 
171

 
35,932

Equity in net income of equity-method investees
(53
)
 

 
(53
)
Net income
$
88,249

 
$
(1,011
)
 
$
87,238

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
0.86

 
$
(0.01
)
 
$
0.85

    Diluted
$
0.85

 
$
(0.01
)
 
$
0.84

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
102,912

 
102,912

 
102,912

    Diluted
104,209

 
104,209

 
104,209

 
 
 
 
 
 

* Net income per common share may not add in certain periods due to rounding
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
 
 
Three Months Ended December 31, 2015
 
Six Months Ended December 31, 2015
 
 
As Reported
 
Adjustment
 
As Revised
 
As Reported
 
Adjustment
 
As Revised
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
56,947

 
$
1,133

 
$
58,080

 
$
88,249

 
$
(1,011
)
 
$
87,238

 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
$
(25,791
)
 
$
136

 
(25,655
)
 
$
(66,084
)
 
497

 
(65,587
)
Change in deferred gains (losses) on cash flow hedging instruments
 
(296
)
 

 
(296
)
 
1,045

 

 
1,045

Change in unrealized gain (loss) on available for sale investment
 
24

 

 
24

 
(132
)
 

 
(132
)
Total other comprehensive income (loss)
 
$
(26,063
)
 
$
136

 
$
(25,927
)
 
$
(65,171
)
 
$
497

 
$
(64,674
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total comprehensive income
 
$
30,884

 
$
1,269

 
$
32,153

 
$
23,078

 
$
(514
)
 
$
22,564

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
Six Months Ended December 31, 2015
 
As Reported
 
Adjustment
 
As Revised
CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
 
 
Net income
$
88,249

 
$
(1,011
)
 
$
87,238

Adjustments to reconcile net income to net cash provided by operating
  activities:
 
 
 
 
 
  Depreciation and amortization
31,409

 
381

 
31,790

  Deferred income taxes
(8,693
)
 
(155
)
 
(8,848
)
  Equity in net income of equity-method investees
(53
)
 

 
(53
)
  Stock based compensation
7,229

 

 
7,229

  Other non-cash items, including unrealized currency (gains)/loss, net
7,812

 

 
7,812

Increase (decrease) in cash attributable to changes in operating assets and
  liabilities, net of amounts applicable to acquisitions:
 
 
 
 
 
  Accounts receivable
(17,231
)
 
(1,181
)
 
(18,412
)
  Inventories
(20,891
)
 
2,598

 
(18,293
)
  Other current assets
5,336

 
20,811

 
26,147

  Other assets and liabilities
2,187

 

 
2,187

  Accounts payable and accrued expenses
4,290

 
(21,443
)
 
(17,153
)
     Net cash provided by operating activities
$
99,644

 
$

 
$
99,644

SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED)
 
Three Months Ended December 31, 2015
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
322,878

 
$
(8,193
)
 
$
314,685

United Kingdom
194,226

 
(2,972
)
 
191,254

Hain Pure Protein
141,706

 
2,486

 
144,192

Rest of World
93,779

 
(473
)
 
93,306

 
$
752,589

 
$
(9,152
)
 
$
743,437

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
48,315

 
$
2,625

 
$
50,940

United Kingdom
18,768

 
(343
)
 
18,425

Hain Pure Protein
18,125

 
37

 
18,162

Rest of World
6,595

 
496

 
7,091

 
$
91,803

 
$
2,815

 
$
94,618

Corporate and Other
(4,081
)
 
(459
)
 
(4,540
)
 
$
87,722

 
$
2,356

 
$
90,078


(1) The information previously reported for the three months ended December 31, 2015 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.

 
Six Months Ended December 31, 2015
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
637,464

 
$
(20,148
)
 
$
617,316

United Kingdom
359,580

 
(7,471
)
 
352,109

Hain Pure Protein
265,694

 
1,553

 
267,247

Rest of World
177,039

 
(2,547
)
 
174,492

 
$
1,439,777

 
$
(28,613
)
 
$
1,411,164

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
92,203

 
$
244

 
$
92,447

United Kingdom
28,972

 
(705
)
 
28,267

Hain Pure Protein
28,396

 
255

 
28,651

Rest of World
9,268

 
246

 
9,514

 
$
158,839

 
$
40

 
$
158,879

Corporate and Other
(13,649
)
 
(880
)
 
(14,529
)
 
$
145,190

 
$
(840
)
 
$
144,350


(1) The information previously reported for the six months ended December 31, 2015 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.